Biotechnology Value Fund L P - Oct 31, 2025 SCHEDULE 13G/A Report for NewcelX Ltd. Common Shares, par value CHF 0.05

Filing Manager
Biotechnology Value Fund L P
Reporting Manager
BVF PARTNERS L P/IL
Security
NewcelX Ltd. Common Shares, par value CHF 0.05
Shares outstanding
4.79M shares
Disclosed Ownership
28.7K shares
Ownership
0.6%
Form type
SCHEDULE 13G/A
Date filed
11/4/2025, 06:57 PM
Date of event
Oct 31, 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 0.3% 15.2K 0 15.2K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 0.3% 15.2K 0 15.2K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 0.3% 11.7K 0 11.7K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 0.3% 11.7K 0 11.7K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.03% 1.33K 0 1.33K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.03% 1.33K 0 1.33K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 0.6% 26.9K 0 26.9K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 0.6% 28.7K 0 28.7K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 0.6% 28.7K 0 28.7K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 0.6% 28.7K 0 28.7K /s/ Mark N. Lampert Mark N. Lampert